Source: International Congress 2019 – Pathogenesis and prognosis of interstitial lung disease of known origin
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Hesse (Hannover, Germany), S. Wollin (Biberach an der Riss, Germany), S. Konzok (Hannover, Germany), M. Niehof (Hannover, Germany), D. Leeming (Herlev, Denmark), S. Rønnow (Herlev, Denmark), J. Sand (Herlev, Denmark), P. Braubach (Hannover, Germany), D. Jonigk (Hannover, Germany), M. Kühnel (Hannover, Germany), G. Warnecke (Hannover, Germany), H. Fieguth (Hannover, Germany), O. Pfennig (Hannover, Germany), K. Sewald (Hannover, Germany), A. Braun (Hannover, Germany). Nintedanib mediates effective modulation of relevant pro-fibrotic biomarkers ex vivo. 1609

Member's Comments

No comment yet.

Related content which might interest you: Anti-oxidative and anti-inflammatory effects of Xanthorrhizol on aeroallergens-induced biological responses in vitro and ex vivo Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets Year: 2019 SDF-1 is an antifibrotic mediator in vivo Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 Clinically validated markers of the extracellular matrix remodelling are altered by potential anti-fibrotic compounds in a human lung fibrosis ex vivo model Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018 In vivo imaging of NF-kB pathway in acute lung inflammation mouse model can predict a pharmacological response Source: Annual Congress 2011 - Cell biology of lung disease Year: 2011 MKP-5 inhibition blunts fibrotic responses in-vitro and in-vivo through negative regulation of TGFB1-induced smad3-signalling Source: International Congress 2018 – New insights in the signalling pathways that underlie IPF pathophysiology Year: 2018 Disease-specific inflammatory environments induce different anti-inflammatory MSC actions that play critical roles in mitigating lung injury Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Circulating MDSC modulate IPF progression by orchestrating immunosuppressive and pro-fibrotic networks Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases Year: 2018 Targeting the Hippo signaling pathway to enhance ex vivo lung epithelial tissue regeneration and maturation Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019 Role of altered immune response in CF and implication for antiinflammatory therapies Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease Year: 2012 Immunotherapy improves inflammatory response and lymphocyte apoptosis as a new therapeutic target in sepsis rat Source: Annual Congress 2009 - Severe sepsis and multiple organ failure Year: 2009 Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo Source: Eur Respir J, 50 (2) 1602367; 10.1183/13993003.02367-2016 Year: 2017 Nintedanib modulates fibrogenesis in activated fibroblasts Source: International Congress 2019 – Oxidative stress, hypoxia and microbial exposure in the pathogenesis of pulmonary disease Year: 2019 In vitro anti-inflammatory activity of the new glucocorticoid ciclesonide in human cells Source: Eur Respir J 2001; 18: Suppl. 33, 95s Year: 2001 Effect of human neutrophil proteases on ex vivo small airway function Source: Annual Congress 2013 –Stress responses and T-cell behaviour in the lung Year: 2013 The inhibitory effect of fenretinide on the expression of inflammatory cytokines, possible molecular target of the drug and its relevance to cystic fibrosis. Source: Research Seminar 2009 - Molecular and Cellular aspects of Chronic Lung Disease Year: 2009 Roflumilast inhibits leukocyte cell interactions in vivo Source: Eur Respir J 2006; 28: Suppl. 50, 224s Year: 2006 PP231 – Released mediators in ex vivo 3D-model of lung fibrosis correspond to elevated serum biomarkers in IPF Source: ERS Lung Science Conference 2021 Year: 2021 Released mediators in ex vivo 3D-model of lung fibrosis correspond to elevated serum biomarkers in IPF Source: Virtual Congress 2021 – Genetics and translational aspects of idiopathic pulmonary fibrosis Year: 2021 MSC extracellular vesicles modulate human macrophages in ARDS towards anti-inflammatory phenotype via transfer of miRNA181-a and PTEN-pSTAT5-SOCS1 signalling Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair Year: 2021